AHMED ELKHANANY to Aged
This is a "connection" page, showing publications AHMED ELKHANANY has written about Aged.
Connection Strength
0.051
-
Prediction of Anthracycline Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer by the MammaPrint 70-Gene Signature for Patients Enrolled in the FLEX Study. JCO Precis Oncol. 2026 Jun; 10(6):e2501285.
Score: 0.017
-
Therapeutic Clinical Trial Eligibility and Enrollment among Women with Breast Cancer: Implications for Understanding Trial Disparities. Ann Surg Oncol. 2025 Mar; 32(3):2038-2044.
Score: 0.015
-
Primary and secondary breast angiosarcoma: single center report and a meta-analysis. Breast Cancer Res Treat. 2019 Dec; 178(3):523-533.
Score: 0.010
-
Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer. Breast Cancer Res Treat. 2018 01; 167(1):89-99.
Score: 0.009